Lumibird shares fell 8.6% after reporting Q1 revenue of €49.7 million, a modest 0.7% YoY increase.
Medical unit revenue dropped 9.2% due to logistics disruptions from the Middle East conflict, pushing €2 million into Q2.
Photonics division grew 11.3% driven by defence and spatial markets up 22%, while industrial‑semiconductor segment rose 24%.
Broker Portzamparc expects growth to resume in H1 as logistics normalize and new products launch.